Small Molecules

22 Oct 2007 OREXIGEN(TM) Therapeutics Reports a Summary of Results from the Phase IIb Trial of Contrave(TM) to Treat Obesity
20 Oct 2007 Miglustat (Zavesca(R)) receives negative opinion from the European Committee for Medicinal Products for Human Use for extension of indication for Niemann Pick type C
20 Oct 2007 Barrier Therapeutics Announces Promising Results From On-Going Phase 2a Study of Pramiconazole in Onychomycosis
20 Oct 2007 European licence for Roche HIV drug Viracept re-established by European Commission
19 Oct 2007 Molecular Insight Pharmaceuticals, Inc. Announces Positive Results of AzedraTM Phase 1 Dosimetry Trial for Neuroendocrine Tumors
19 Oct 2007 FDA Announces Revisions to Labels for Cialis, Levitra and Viagra
19 Oct 2007 European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
19 Oct 2007 Abraxis BioScience Receives a Positive Opinion in Europe from the CHMP for the Approval of ABRAXANE for the Treatment of Metastatic Breast Cancer
19 Oct 2007 Adolor Corporation Initiates Second Phase 2 Study of Novel Delta Agonist
19 Oct 2007 Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response
18 Oct 2007 OREXIGEN(TM) Therapeutics Initiates its Third Phase III Trial for Contrave(TM) to Treat Obesity
18 Oct 2007 Theravance Reports Additional Data on Investigational Compound TD-5108 at 2007 American College of Gastroenterology Annual Scientific Meeting
18 Oct 2007 Tezampanel, TorreyPines Therapeutics’ Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego
18 Oct 2007 Cytopia's lead anticancer compound shows promise in multiple myeloma
18 Oct 2007 EnVivo Pharmaceuticals Announces Progress on Major Drug Programs Focusing on Alzheimer’s, Schizophrenia and Huntington's Diseases
18 Oct 2007 Pro-Pharmaceuticals Novel Carbohydrate Compounds Reverse Liver
18 Oct 2007 Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
17 Oct 2007 Hollis-Eden Pharmaceuticals Commencing Phase I/II Clinical Trial with TRIOLEX(TM) (HE3286) in Obese, Insulin Resistant Volunteers
17 Oct 2007 Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy
17 Oct 2007 FDA Approves IXEMPRA(TM) (ixabepilone), a Semi-Synthetic Analog of Epothilone B, for the Treatment of Advanced Breast Cancer
17 Oct 2007 Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
17 Oct 2007 Curis, Inc. Announces Initiation of Expansion Cohort in Collaborator Genentech's Phase I Clinical Trial of a Systemically Administered Hedgehog Antagonist
16 Oct 2007 Lexicon Reports Initial Clinical Trial Results for LX1031, An Investigational New Drug For Irritable Bowel Syndrome
16 Oct 2007 Evotec Reports Positive Top-Line Results in Phase II Study with EVT 201 in Elderly Insomniacs with Daytime Sleepiness
16 Oct 2007 Xanthus Presents Data from FLT3 Autoimmune Program Supporting Novel

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up